1. Academic Validation
  2. Blockade of JAK2 retards cartilage degeneration and IL-6-induced pain amplification in osteoarthritis

Blockade of JAK2 retards cartilage degeneration and IL-6-induced pain amplification in osteoarthritis

  • Int Immunopharmacol. 2022 Dec;113(Pt A):109340. doi: 10.1016/j.intimp.2022.109340.
Zhaxi Mima 1 Ke Wang 2 Mengmeng Liang 3 Yu Wang 1 Chaozhi Liu 1 Xiaoyu Wei 4 Fei Luo 4 Piming Nie 5 Xuewei Chen 3 Yuan Xu 6 Qinyu Ma 7
Affiliations

Affiliations

  • 1 Shigatse Branch, Xinqiao Hospital, Third Military Medical University, Shigatse 857000, China.
  • 2 College of Bioengineering, Chongqing University, 400030 Chongqing, China.
  • 3 Institute of Environment and Operational Medicine, Academy of Military Medicine Sciences, Academy of Military Sciences, Tianjin 300050, China.
  • 4 Department of Orthopedics, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
  • 5 Department of Orthopedics, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China.
  • 6 Department of Orthopedics, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China. Electronic address: 15123161526@163.com.
  • 7 Shigatse Branch, Xinqiao Hospital, Third Military Medical University, Shigatse 857000, China; Department of Orthopedics, Southwest Hospital, Third Military Medical University, Chongqing 400038, China. Electronic address: maqinyu@tmmu.edu.cn.
Abstract

Osteoarthritis (OA) is a complex chronic inflammatory disease characterized by articular degeneration and pain. Recent studies have identified interleukin 6 (IL-6) as a potential mediator leading to OA, but the therapeutic effects of inhibiting IL-6 signaling in intreating OA need to be further clarified. Here, we identified the intracellular signal transduction induced by recombinant IL-6 and focused on the impact of tyrphostin AG490 (a JAK2 Inhibitor) on cartilage degeneration and OA pain. We found that IL-6 increased the inflammatory cytokines production and hypertrophic markers expression of primary mouse chondrocytes by activating JAK2/STAT3. Meanwhile, tyrphostin AG490 significantly attenuated articular degeneration and osteophyte formation in experimental mice with anterior cruciate ligament transection (ACLT) surgery. In vivo electrophysiological experiments showed that articular stimulation of IL-6 induced spinal hyperexcitability, which was prevented by coinjection of tyrphostin AG490. Specifically, compared with DMSO-treated ACLT mice, tyrphostin AG490 improved ambulate activity of mice and abolished the enhancement of serum bradykinin induced by IL-6. Together, we suggest that tyrphostin AG490 protected against progression of OA and improved OA prognosis by reducing cartilage degeneration and arthritis pain. Our findings provide further evidence for targeting IL-6 signaling in the treatment of OA.

Keywords

Cartilage degeneration; IL-6; Osteoarthritis pain; Tyrphostin AG490.

Figures
Products